Sign in
Back
Safety and efficacy of nivolumab compared with other regimens in patients with melanoma: A network meta-analysis
Journal article   Open access  Peer reviewed

Safety and efficacy of nivolumab compared with other regimens in patients with melanoma: A network meta-analysis

Mohammad Almohideb
Medicine (Baltimore), Vol.101(35), pp.E29390-e29390
02/09/2022
DOI: https://doi.org/10.1097/MD.0000000000029390
PMID: 36107612

Abstract

ipilimumab melanoma, nivolumab Systematic Review and Meta-Analysis
Melanoma is a cancerous tumor that develops from melanocytes in the epidermal basal layer of the skin. It is a fatal skin cancer and the third most common kind of cutaneous tumor. We aim to evaluate the effect of nivolumab in melanoma patients compared with other regimens
url
https://doi.org/10.1097/MD.0000000000029390View
Published (Version of record) Open

Metrics

1 Record Views

Details